Statin Benefits Outweigh Liver Toxicity Risks In Most Patients – Editorial
This article was originally published in The Tan Sheet
Executive Summary
The benefits of statins offset the potential risks of liver toxicity in most patients, but the drugs may be inappropriate for certain subgroups in an OTC setting, according to a recent editorial in the American Journal of Cardiology
You may also be interested in...
Pravastatin Reduces Mortality 10 Years After Use – Study
Results of a follow-up primary prevention trial finding treatment with pravastatin provided ongoing cardiac event risk reduction 10 years later could strengthen the case for OTC statins
Pravastatin Reduces Mortality 10 Years After Use – Study
Results of a follow-up primary prevention trial finding treatment with pravastatin provided ongoing cardiac event risk reduction 10 years later could strengthen the case for OTC statins
Pravastatin Reduces Mortality 10 Years After Use – Study
Results of a follow-up primary prevention trial finding treatment with pravastatin provided ongoing cardiac event risk reduction 10 years later could strengthen the case for OTC statins